Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoyuki Morishita is active.

Publication


Featured researches published by Tomoyuki Morishita.


Biochemical and Biophysical Research Communications | 1991

Receptors for gastrin on gastric carcinoid tumor membrane of Mastomys natalensis

Tsutomu Chiba; Yoshikazu Kinoshita; Tomoyuki Morishita; Hirohisa Nakata; Akira Nakamura; Syun Hosoda

Specific binding sites for human gastrin I (gastrin) were identified in a crude membrane preparation from the gastric carcinoid tumor of Mastomys (Praomys) natalensis. The binding of 125I-gastrin to the carcinoid tumor membrane was saturable, and Scatchard analysis of the data revealed a single class of binding site with a dissociation constant of 139.2 pM and a maximal binding capacity of 23.5 fmol/mg protein. Gastrin and CCK8 equipotently and dose-dependently displaced the binding of 125I-gastrin to the membrane. GTP but not ATP decreased 125I-gastrin binding to the membrane, and removal of Mg2+ attenuated this inhibitory action of GTP. The GTP-induced reduction of 125I-gastrin binding was found to be due to a decrease in binding affinity without a change in binding capacity. These results clearly indicate the presence of specific binding sites for gastrin, probably coupled to guanine nucleotide-binding protein, in the carcinoid tumor membrane of Mastomys, and suggest that gastrin has possible biological actions on these tumors.


Diabetes | 1990

Calcitonin Gene—Related Peptide and Induction of Hyperglycemia in Conscious Rats In Vivo

Akinori Yamaguchi; Tsutomu Chiba; Tomoyuki Morishita; Akira Nakamura; Tetsuya Inui; Toshiyuki Yamatani; Kazuo Chihara; Masaaki Fukase; Takuo Fujita

The effect of calcitonin gene-related peptide (CGRP) on glucose metabolism was investigated in conscious and unrestrained rats in vivo. Intravenous injection of rat CGRP (5.67 and 0.567 nmol/kg) caused a significant, dose-dependent increase in plasma glucose concentration and a simultaneous dose-dependent increase in plasma insulin level. In contrast, plasma glucagon level was not changed. On the other hand, intravenous infusion of CGRP (46.6 pmol · kg−1 · min−1) decreased tolerance to intragastric administration of glucose (IGGTT). Plasma insulin response to IGGTT, however, was not affected by CGRP infusion. Moreover, although intravenous injection of CGRP (5.67 nmol/kg) elicited a significant increase in plasma epinephrine and norepinephrine concentrations, concomitant administration of epinephrine and norepinephrine, inducing a more prominent rise in plasma catecholamines than those induced by CGRP, affected neither plasma glucose nor insulin levels. Finally, plasma insulin levels obtained by simulating CGRP-induced changes in plasma glucose or glucose plus catecholamine levels by infusion of glucose or glucose plus catecholamines were not different from those induced by CGRP injection. These results suggest that CGRP has a hyperglycemic action that is not mediated by sympathetic outflow in conscious rats, and inhibition of insulin secretion, if any, does not play a major role in this hyperglycemic action of CGRP. We have demonstrated specific CGRP receptors linked to adenylate cyclase activation in rat liver plasma membranes; this hyperglycemic effect of CGRP in vivo may be partly due to its direct action on the liver.


Life Sciences | 1989

Presence and release of calcitonin gene-related peptide in rat stomach

Tetsuya Inui; Tsutomu Chiba; Yasuhiko Okimura; Tomoyuki Morishita; Akira Nakamura; Akinori Yamaguchi; Toshiyuki Yamatani; Kazuo Chihara; Takuo Fujita

Immunoreactive (IR)-calcitonin gene-related peptide (CGRP) was identified throughout the entire stomach of rats, being most highly concentrated in the pyloric region, and the concentrations in muscular layers being higher than those in mucosal layers. In addition, IR-CGRP was also present in the venous effluent from isolated perfused rat stomach, and its release was stimulated by dibutyryl cyclic AMP or theophylline but not by glucagon. Gel chromatography as well as HPLC of both tissue extracts and gastric perfusate showed three identical major peaks of IR-CGRP, one of which coeluted with synthetic CGRP. These results suggest that CGRP in the stomach plays a role in the regulation of gastric function.


Life Sciences | 1989

Prostaglandin E2 and F2α inhibit growth of human gastric carcinoma cell line KATO III with simultaneous stimulation of cyclic AMP production

Akira Nakamura; Tsutomu Chiba; Toshiyuki Yamatani; Akinori Yamaguchi; Tetsuya Inui; Tomoyuki Morishita; Takuo Fujita

The effects of prostaglandins (PGs) on the growth of human gastric carcinoma cell line KATO III were investigated. PGE2 as well as PGF2 alpha significantly and dose-dependently inhibited the growth of this gastric carcinoma cell line (PGE2 greater than PGF2 alpha). This inhibition of cell growth by the PGs was associated with the increase in cyclic AMP production (PGE2 greater than PGF2 alpha), whereas inositol-phospholipid turnover was not affected by either PGE2 or PGF2 alpha as assessed by the formation of 3H-inositol phosphates. Furthermore, the proliferation of these gastric carcinoma cells was also suppressed by the administration of forskolin as well as of dibutyryl cyclic AMP. These results suggest that PGE2 and PGF2 alpha inhibit the growth of cultured human gastric carcinoma cells KATO III via stimulation of cyclic AMP production.


Diabetes Research and Clinical Practice | 1992

Effects of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide (CGRP) on glucose metabolism in the rat

Tomoyuki Morishita; Akinori Yamaguchi; Toshiyuki Yamatani; Akira Nakamura; Noriyuki Arima; Yukimasa Yamashita; Hirohisa Nakata; Takuo Fujita; Tsutomu Chiba

In this study, we compared the effects of islet amyloid polypeptide (IAPP) and calcitonin gene-related peptide (CGRP) on glucose metabolism both in vivo and in vitro in the rat. Intravenous injection of rat CGRP caused a significant increase in plasma glucose concentration with a simultaneous increase in plasma insulin levels, whereas neither IAPP-NH2 nor IAPP-COOH had any effect. Moreover, intravenous infusion of CGRP decreased tolerance to intragastric administration of glucose (O-GTT) without altering plasma insulin levels, but again IAPPs had no effect. On the other hand, 125I-[Tyr0]rat CGRP specifically bound to the liver plasma membrane, and not only CGRP but also IAPP-NH2 dose-dependently displaced the specific binding of 125I-[Tyr0] CGRP, whereas IAPP-COOH had no effect. Conversely, CGRP as well as IAPP-NH2 but not IAPP-COOH evoked dose-dependent activation of adenylate cyclase in the membranes, and these effects were significantly inhibited by a CGRP receptor antagonist, human CGRP-I(8-37). However, neither CGRP nor IAPP-NH2 had any effect on glucose production in rat isolated hepatocytes. These results suggest that (1) IAPP-NH2 but not IAPP-COOH induces adenylate cyclase activation via CGRP receptors on rat liver plasma membranes, and (2) CGRP might not involve its action on the liver in the changes of glucose metabolism.


Journal of Bone and Mineral Metabolism | 1999

Changes of regional distribution of bone mineral according to age, gender, and activity

Takuo Fujita; Yoshio Fujii; Tomoyuki Morishita; Takehisa Inoue

Abstract: To assess the pattern of bone mineral distribution over various parts of the skeletal system depending on age, gender, and level of activity, bone mineral content of the head, arms, trunk, and legs was measured and expressed as percentage of the whole-body mineral content (H%, A%, T%, and L%) by a QDR-4500 (Hologic) in 814 subjects between ages of 20 and 99, 205 men and 609 women. In ambulant, self-supporting subjects classified as ADL 1, women had higher H%, lower A%, and lower L% at each age group than in men. In subjects older than 60 years of age, H% increased and L% decreased markedly in women, whereas these changes were milder in men. Women, but not men, showed definite fall of L% and rise of H% along with the decrease of the level of activity. In hospitalized female subjects with a lower level of activity, but not in ambulatory female subjects, fall of L% and rise of H% was noted after 1 year, unlike the results in their male counterparts. Mineral distribution changes over the whole body characterized by age, gender, and activity may serve as new indices for evaluation of skeletal changes caused by aging, lifestyle, and disease.


American Journal of Physiology-endocrinology and Metabolism | 1989

Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37)

Tsutomu Chiba; Akinori Yamaguchi; Toshiyuki Yamatani; Akira Nakamura; Tomoyuki Morishita; Tetsuya Inui; Masaaki Fukase; Toshiharu Noda; Takuo Fujita


Diabetes | 1990

Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes.

Tomoyuki Morishita; Akinori Yamaguchi; Tsunenori Fujita; Tsutomu Chiba


Biochemical and Biophysical Research Communications | 1988

Receptors for calcitonin gene-related peptide on the rat liver plasma membranes.

Akinori Yamaguchi; Tsutomu Chiba; Yasuhiko Okimura; Toshiyuki Yamatani; Tomoyuki Morishita; Akira Nakamura; Tetsuya Inui; Toshiharu Noda; Takuo Fujita


Endocrinology | 1988

Calcitonin Gene-Related Peptide Stimulates Adenylate Cyclase Activation via a Guanine Nucleotide-Dependent Process in Rat Liver Plasma Membranes

Akinori Yamaguchi; Tsutomu Chiba; Toshiyuki Yamatani; Tetsuya Inui; Tomoyuki Morishita; Akira Nakamura; Seizo Kadowaki; Masaaki Fukase; Takuo Fujita

Collaboration


Dive into the Tomoyuki Morishita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge